News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Osmotics Pharma, Inc. (OPI) Retains New York-Based Investor Relations Firm



10/19/2005 5:13:02 PM

BOULDER, Colo., April 20, 2005 (PRIMEZONE) -- Following the recent announcement of its intent to merge with OnSource Corporation ("OnSource") (OTCBB:OSCE), Osmotics Pharma, Inc. (OPI) has engaged The Investor Relations Group, Inc. (IRG), based in New York City, to serve as its financial relations and corporate communications agency of record.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES